Agilent forms collaboration in biomolecular characterization

Skip to Navigation


  • Published: Jan 30, 2018
  • Source: Agilent Technologies
  • Suppliers: Agilent Technologies
  • Channels: Ion Chromatography / Sample Preparation / HPLC / Gas Chromatography / Detectors / Laboratory Informatics / Proteomics & Genomics / Electrophoresis / Chemometrics & Informatics / NMR Knowledge Base / Atomic / MRI Spectroscopy / Base Peak / Raman / Proteomics / X-ray Spectrometry / UV/Vis Spectroscopy / Infrared Spectroscopy

Agilent Technologies has formed a strategic scientific collaboration with the University of Southern California (USC) Michelson Center for Convergent Bioscience to create an Agilent Center of Excellence (CoE) in Biomolecular Characterization.

Intended as a state-of-the-art research facility, the center will be housed in Michelson Hall, which opened at the university in October 2017. The aim of the center is to establish a convergence of researchers across science and engineering to work together on multidisciplinary approaches for the development of improved health care through new drugs, diagnostics and medical devices. The Agilent CoE will provide a collaborative scientific environment with access to new Agilent instrumentation and technologies for undergraduate and graduate students, and local customers. It will also offer broad exposure to researchers who are leaders in their respective fields.

“Agilent’s collaboration with the Michelson Center is an excellent example of how academia and industry can work together, sharing knowledge and expertise to shorten the timeline between scientific discoveries and real-world applications,” said Darlene Solomon, senior vice president and chief technology officer for Agilent. “Convergent bioscience research requires successful collaboration across multiple disciplines – a holistic approach that is central to Agilent’s view of the future.”

Key to the Agilent CoE will be a collaboration with renowned USC Michelson Center for Convergent Bioscience principal investigator Valery Fokin. Research at the Fokin lab at USC focuses on chemical reactivity and biological interactions at the molecular level. The lab will contribute to multiple collaborative drug discovery projects ranging from chemical synthesis of screening and focused libraries and biological assay implementation to the development of targeted drug delivery systems, diagnostics and vaccines.

“As convergent bioscience becomes a major contributor to scientific knowledge and ultimately improved human health, academic and industry collaboration will play a key role,” said Stephen Bradforth, divisional dean for natural sciences and mathematics at the USC Dornsife College of Letters, Arts and Sciences. “I’m pleased that Agilent has the vision to support our efforts in this important emerging research field.”

Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Most Viewed

Copyright Information

Interested in spectroscopy? Visit our sister site

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved